stock market day trading


Cemtrex (NASDAQ:CETX) is a small industrials company out of Long Island, NY. You’ve likely never heard of it, but it immediately needs to be on your radar because of its low valuation, high appetite for growth, and positioning in several different, but favorable global markets. This stock is a classic high risk, high reward small-cap with an attractive, yet unrecognized growth profile. Based upon a projected fair value of $19.41/share, the stock has implied upside of 163%.

Source: Cemtrex


Background and Quick Trading Data

Cemtrex is a small-cap stock with a market capitalization of just $72 million. It’s volatility is massively high and to put it blatantly, management even wrote in the risk factors section of their recent 10-K, “Investing in our common stock involves a high degree of risk.” Having been in the position for a couple weeks now, I can tell you that some days you’ll be up over 10%, but other days you’ll suffer 6% losses. If, after reading this pitch, you choose to buy the stock, think about allocation carefully as to not subject your entire portfolio to an undue level of risk. Liquidity is not yet ample enough for major institutional investors to take positions in, as they risk a liquidity crunch in the event of a sell-off, however it’s perfectly adequate for retail investors. The rolling three month average daily volume is just over 370,000 shares. The stock’s beta is 1.16.

stock market day trading: MPL X LP(MPLX)


Advisors’ Opinion:

  • [By Ben Levisohn]

    JPMorgan analyst Phil Gresh and team explain what they got wrong about Marathon Petroleum (MPC), as they cut its rating to Neutral from Overweight following yesterday’s disastrous financial results from MPLX (MPLX):

  • [By Garrett Cook]

    Lastly, Citi says Marathon Petroleum (NYSE: MPC) and MPLX LP (NYSE: MPLX) remain Buy rated the heels of benefits derived from strong product demand and the NGL recovery.

stock market day trading: Female Health Company (The)(FHCO)


Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Female Health Co (NASDAQ: FHCO) were down 15 percent to $1.46 as the company reported that it has entered into a merger agreement with Aspen Park Pharma.

stock market day trading: Logitech International S.A.(LOGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Mad Catz Interactive, Inc. (USA) (NYSE: MCZ) shares were also up, gaining 35 percent to $0.260 as the company disclosed that it has sold its Saitek simulation product line to Logitech International SA (USA) (NASDAQ: LOGI) for $13 million in cash.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer once again sat down with Bracken Darrell, president and CEO of Logitech (LOGI) , the computer accessory maker with shares that are up 27% since Cramer last checked in back in November.

stock market day trading: HTG Molecular Diagnostics, Inc.(HTGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 190 percent to $11.42 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares were also up, gaining 136 percent to $2.95. HTG Molecular Diagnostics disclosed that its new direct-target sequencing chemistry will be launched in the first quarter.

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 175 percent to $10.80 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus) Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha) HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million. ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million. Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30. Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share. Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19. Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash. TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25. Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash. CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus) Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay. Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan. bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives. Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss. Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter. FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy. PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast. Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday. Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe
  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 106 percent to $4.40 after the molecular profiling company confirmed regulatory approval for its products in Europe. HTG Molecular announced that it has obtained CE marking in the European Union for its HTG EdgeSeqALKPlus Assay EU, an in vitro diagnostic assay which is intended to measure and analyze mRNA ALK gene rearrangements in formalin-fixed, paraffin-embedded lung tumor specimens from patients previously diagnosed with non-small cell lung cancer.

stock market day trading: Akebia Therapeutics, Inc.(AKBA)


Advisors’ Opinion:

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

stock market day trading: Timken Company (The)(TKR)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Timken (TKR) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $40 price target. The valuation is less attractive, as the stock is up 35% year-to-date, analysts said. 

Leave a Reply

Your email address will not be published. Required fields are marked *